MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr | ₹0.93 Cr | ₹1.27 Cr |
What is the latest Contingent Liabilities ratio of MOREPEN LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹9.76 Cr |
Mar2023 | ₹6.66 Cr |
Mar2022 | ₹2.64 Cr |
Mar2021 | ₹0.93 Cr |
Mar2020 | ₹1.27 Cr |
How is Contingent Liabilities of MOREPEN LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹9.76 Cr | 46.52 | |
Mar2023 | ₹6.66 Cr | 152.33 | |
Mar2022 | ₹2.64 Cr | 184.90 | |
Mar2021 | ₹0.93 Cr | -26.72 | |
Mar2020 | ₹1.27 Cr | - |
Compare Contingent Liabilities of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹3,436.0 Cr | -1.6% | -5% | 9.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | -1.6% |
-5% |
9.2% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses